跳至主要内容
临床试验/CTIS2024-511877-31-00
CTIS2024-511877-31-00进行中(未招募)1 期

ong-term pain modulation by intravenous esketamine in Complex Regional Pain Syndrome: a non-inferiority study - NL77785.078.21

Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)0 个研究点目标入组 60 人开始时间: 2024年4月10日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • Age = 18 years, Meeting the new International Association for the Study of Pain (IASP) diagnostic criteria for CRPS (the Budapest Criteria) or having met the new IASP diagnostic criteria of CRPS (CRPS with Remission of Some features”), Willing and capable to participate in the study., CRPS in one upper extremity and/or CRPS in one lower extremity, Treatment in an elective setting, Adequate comprehension of the Dutch language

排除标准

  • Contraindications to and precautions for use of subanesthetic doses of ketamine for chronic pain are listed by Cohen et al. and the Dutch CRPS guidelines and our clinical protocol

研究者

相似试验